Okairos AG - Ownership and Business Overview

Life ScienceCompany

Okairos AG Ownership

Who owns Okairos AG?

Okairos AG is owned by GlaxoSmithKline. It was acquired on May 29, 2013.

Okairos AG Business Overview

Where is Okairos AG headquartered?

Okairos AG is headquartered in Basel, Switzerland.

What sector is Okairos AG in?

Okairos AG is a life science company.

When was Okairos AG founded?

Okairos AG was founded in 2007.

Life Science M&A Summary in 2013

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2013. The largest life science acquisition in 2013 was Onyx Pharmaceuticals - which was acquired by Amgen for $10.4B.

Join Mergr to view all 191 acquisitions of life science companies in 2013, including 25 acquisitions by private equity firms, and 166 by strategics.

Okairos AG

Elisabethenstrasse 3,
Basel, 4051
Switzerland,
+41 61 270 35 35
www.okairos.com

Okairos - is a non-listed clinical-stage biopharmaceutical company, developing genetic vaccines for major infectious diseases - including malaria, hepatitis C, HIV, respiratory syncytial virus and cancer - using a novel proprietary technology. The company is also pursuing therapeutic vaccines to treat cancer.


Company Summary

SECTOR

Life Science

Established

2007

 Subscribe to unlock this and 201,882
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Okairos AG

Life Science Companies , Switzerland Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Switzerland Companies

Largest Switzerland Companies , Acquisitive Switzerland Companies , Recently Acquired Switzerland Companies , Recently Sold Switzerland Companies , Private Switzerland Companies , Public Switzerland Companies , Acquired Switzerland Companies , PE Backed Switzerland Companies
Mergr

Product

Company

Legal